Two more brand names containing molnupiravir, which is used to treat light and moderate forms of Covid, have been authorized in a fast-track procedure by the Moldovan Agency for Medicines and Medical Devices.

These are Movfor 200 mg in capsules, and Molxvir 200 mg in capsules, with both manufacturers based in India.

The Agency also authorized Nebivolol STADA 5 mg in tablets of Spain’s Laboratorio Stada. Nebivolol, a cardioselective beta blocker used for treating hypertension, is covered by the National Health Insurance drug plan.